SHIM
BIIB icon

Stone House Investment Management’s Biogen BIIB Stock Holding History

Stone House Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14
Closed -$1.76K – 730
2025
Q2 		$1.76K Sell
14
-15
-52% -$1.87K ﹤0.01% 416
2025
Q1 		$3.97K Buy
+29
New +$4.15K ﹤0.01% 338
2024
Q4 		– Sell
-96
Closed -$18.6K – 84
2024
Q3 		$18.6K Sell
96
-20
-17% -$4.18K ﹤0.01% 182
2024
Q2 		$26.9K Sell
116
-29
-20% -$6.3K 0.01% 165
2024
Q1 		$31.3K Buy
+145
New +$34K 0.01% 159

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Stone House Investment Management's BIIB Position: Q3 2025 in Review

Stone House Investment Management sold out of Biogen (BIIB) in Q3 2025, closing a stake of 14 shares — an estimated $1.76K sold.

Stone House Investment Management first reported a position in BIIB in Q1 2024 and held it in 5 quarters. The position peaked at $31.3K in Q1 2024. 905 funds tracked by Wall St. Rank hold BIIB as of Q3 2025.

  • Stone House Investment Management reported no remaining Biogen position as of Q3 2025 after selling out during the quarter.
  • Stone House Investment Management sold 14 Biogen shares in Q3 2025, an estimated $1.76K.
  • Stone House Investment Management first reported a position in Biogen in Q1 2024 and held it in 5 quarters.
  • Stone House Investment Management's Biogen position peaked at $31.3K in Q1 2024.
  • 905 funds tracked by Wall St. Rank held Biogen as of Q3 2025.

Based on Stone House Investment Management's 13F filing for Q3 2025, filed 27 Oct 2025.